MENU
+Compare
BGLC
Stock ticker: NASDAQ
AS OF
Jan 23, 11:58 AM (EDT)
Price
$0.34
Change
-$0.02 (-5.56%)
Capitalization
11.21M

BGLC BioNexus Gene Lab Corp Forecast, Technical & Fundamental Analysis

BGLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BGLC with price predictions
Jan 08, 2025

BGLC in +64.71% Uptrend, rising for three consecutive days on January 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BGLC advanced for three days, in of 72 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on December 30, 2024. You may want to consider a long position or call options on BGLC as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BGLC just turned positive on December 27, 2024. Looking at past instances where BGLC's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

BGLC moved above its 50-day moving average on January 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BGLC crossed bullishly above the 50-day moving average on January 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BGLC moved out of overbought territory on January 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 13 similar instances where the indicator moved out of overbought territory. In of the 13 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

BGLC broke above its upper Bollinger Band on January 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BGLC entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BGLC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.157) is normal, around the industry mean (3.628). P/E Ratio (0.000) is within average values for comparable stocks, (34.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.088). Dividend Yield (0.000) settles around the average of (0.038) among similar stocks. P/S Ratio (1.084) is also within normal values, averaging (93.186).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGLC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

View a ticker or compare two or three
BGLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry ChemicalsSpecialty

Profile
Fundamentals
Details
Industry
N/A
Address
No. 8 Jalan Kerinchi
Phone
+60 122126512
Employees
15
Web
https://www.bionexusgenelab.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QFIN39.480.50
+1.28%
Qifu Technology
DSP20.15-0.41
-1.99%
Viant Technology
LW60.87-1.83
-2.92%
Lamb Weston Holdings
VTOL35.24-1.33
-3.64%
Bristow Group
LTRY0.33-0.02
-5.34%
Lottery.com

BGLC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BGLC has been loosely correlated with ECL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BGLC jumps, then ECL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLC
1D Price
Change %
BGLC100%
-3.22%
ECL - BGLC
33%
Loosely correlated
+0.23%
AVTR - BGLC
16%
Poorly correlated
+1.52%
ADKIL - BGLC
11%
Poorly correlated
N/A
ALTO - BGLC
10%
Poorly correlated
-3.87%
CNEY - BGLC
9%
Poorly correlated
-8.13%
More